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Abstract Mathematical models of radiation carcinogene-
sis are important for understanding mechanisms and for
interpreting or extrapolating risk. There are two classes of
such models: (1) long-term formalisms that track pre-
malignant cell numbers throughout an entire lifetime but
treat initial radiation dose–response simplistically and (2)
short-term formalisms that provide a detailed initial dose–
response even for complicated radiation protocols, but
address its modulation during the subsequent cancer latency
period only indirectly. We argue that integrating short- and
long-term models is needed. As an example of this novel
approach, we integrate a stochastic short-term initiation/
inactivation/repopulation model with a deterministic two-
stage long-term model. Within this new formalism, the
following assumptions are implemented: radiation initiates,
promotes, or kills pre-malignant cells; a pre-malignant cell
generatesaclone,which,ifitsurvives,quicklyreachesasize
limitation; the clone subsequently grows more slowly and
can eventually generate a malignant cell; the carcinogenic
potential of pre-malignant cells decreases with age.
Introduction
Short- and long-term biologically based models
Biologically motivated mathematical modeling of back-
ground and ionizing radiation-induced carcinogenesis has a
history spanning more than 50 years (Nordling 1953). Many
of the models can be characterized as short-term, in that they
focus on processes occurring during and shortly after irradi-
ation (Hahnfeldtand Hlatky1998; Radivoyevitchetal.2001;
Mebust et al. 2002; Schollnberger et al. 2002; Sachs and
Brenner2005;Hofmannetal.2006;Shuryaketal.2006;Little
2007;Sachsetal.2007;SchneiderandWalsh2008).Themain
advantageofsuchmodelsisthattheyprovideadetailedinitial
dose–response relation for short-term endpoints, which are
usedassurrogatesfor carcinogenesis.Themaindisadvantage
is that the possibly substantial modulations of the magnitude
and shape of this initial dose–response during the lengthy
period (multiple years-decades) between irradiation and
manifestation of typical solid tumors are not considered
mechanistically.
In contrast, another class of biologically motivated
models can be characterized as long-term, in the sense that
they track carcinogenesis rates throughout the entire life
span, e.g., the Armitage-Doll model (Armitage and Doll
1954; Armitage 1985), the Moolgavkar-Venzon-Knudson
two-stage clonal expansion (TSCE) model (Moolgavkar
1978, 1980; Moolgavkar and Knudson 1981), the two-stage
logistic model (Sachs et al. 2005), and many others
(Yakovlev and Polig 1996; Pierce and Mendelsohn 1999;
Wheldon et al. 2000; Little and Wright 2003; Pierce and
Vaeth 2003; Ritter et al. 2003; Little and Li 2007). The
main advantage of long-term models is the more detailed
treatment of slow carcinogenesis processes, including the
modulation of the radiation dose–response during the long
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dose–response is typically treated in a non-mechanistic,
phenomenological manner.
The need for a new approach: integration
of long- and short-term models
The lack of detailed treatment of radiation-speciﬁc effects
typically limits risk predictions from long-term models to
exposure conditions where a simple dose–response rela-
tionship holds. Exposures where this relationship is more
complex, such as high fractionated radiotherapeutic doses
that can lead to treatment-induced cancers in nearby organs
(Travis et al. 1996, 1997, 2002, 2003; van Leeuwen et al.
2003; Travis et al. 2005) are difﬁcult to describe with
current long-term models. Conversely, the more detailed
dose–responses produced by sophisticated short-term
models can be scaled to cancer risks only by considering
the effects of factors such as background risks, age at
exposure, and time since exposure, which are not explicitly
taken into account by the short-term formalisms. A new,
uniﬁed approach of integrating short- and long-term tech-
niques is needed, where a detailed initial dose–response for
pre-malignant cell numbers is produced over a wide range
of doses, and changes to the shape of this dose–response
during the latency period before the development of cancer
are also analyzed in detail. A schematic representation of
model uniﬁcation is provided in Fig. 1.
Motivations for the speciﬁc uniﬁcation used here
Here, we provide a speciﬁc example of integrating short-
and long-term radiation carcinogenesis models. In that a
variety of short- and long-term models have been pro-
posed, our approach should be considered as illustrative,
intended to investigate the practicality of integrating the
two model types. The goal was to produce a novel for-
malism, which can describe typical patterns of background
and radiogenic carcinogenesis with the smallest possible
number of adjustable parameters. This goal required
multiple simplifying assumptions about the complex
multi-step carcinogenesis process. We suggest that for the
purposes of generating a preliminary integrated model, the
consequent reduction in biological realism is compensated
by the reduction in model complexity and number of
parameters. More complicated examples of unifying long-
and short-term models are certainly possible, e.g., models
analyzing multiple pre-malignant cell stages, analyzing
genomic instability, and/or analyzing stochastic effects at
both time scales, rather than just at short-time scales as we
shall do.
Short-term model
The short-term part of our model (Fig. 1a) is the more
mathematically intensive part of the integrated formalism.
It is based on existing initiation, inactivation and repopu-
lation (iir) models originally designed for analyzing second
cancers induced by radiotherapy (Lindsay et al. 2001;
Sachs and Brenner 2005; Shuryak et al. 2006; Little 2007;
Sachs et al. 2007). This short-term part analyzes normal
and pre-malignant stem cells during complex radiation
exposure regimens and during the following weeks of tis-
sue recovery. It tracks individual pre-malignant cell clones
rather than just the total number of pre-malignant cells. The
probability that a pre-malignant clone becomes extinct
during radiotherapy can be substantial, so a fully stochastic
formalism is used for the population dynamics of pre-
malignant cells.
Long-term model
The long-term part of our model (Fig. 1b) approximates
carcinogenesis by a process where normal target (e.g.,
stem) cells can be initiated by spontaneous or radiation-
induced mutations to become pre-malignant cells, which
can clonally expand and perhaps produce by mutation a
fully malignant cell, which then gives rise to cancer after
some lag period. The basic assumptions are somewhat
similar to those of several long-term models cited above,
including the TSCE model. Speciﬁcally, our long-term
formalism uses the following main assumptions:
Fig. 1 A general scheme of short- and long-term processes governing
the total number of pre-malignant cells. Details are discussed
throughout the main text. As the individual ages, the number of
viable pre-malignant cells grows, but the curve may turn over and
decrease at very old age (blue line in the main graph). This pattern
parallels background cancer incidence, since cancer risk is assumed to
be proportional to the number of pre-malignant cells (discussed in the
text). Radiation exposure (e.g., radiotherapy for an existing cancer)
initially causes the number of pre-malignant cells to decrease due to
cell killing (red line). After exposure stops, the irradiated tissues
recover, allowing pre-malignant cells to repopulate and reach a
number higher than was present before irradiation, i.e., a net excess
radiogenic cancer risk is produced. Fluctuations in the number of pre-
malignant cells throughout the irradiation and recovery periods (i.e.,
the short-term processes) are shown in the inset graph
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123• Normal and pre-malignant stem cells are located in
speciﬁctissueniches(Slack2000;Borthwicketal.2001;
Potten and Booth 2002; Bennett et al. 2003; Fuchs et al.
2004;GhazizadehandTaichman2005;LiandXie2005).
We here have in mind a general concept of a niche,
including,e.g.,aclonewhosefurthergrowthisprevented
or slowed by any kind of micro-environmental con-
straints.Thenumberofnichesperorgan,andthenumber
of normal or pre-malignant stem cells per niche, is
homeostatically regulated (Fuchs et al. 2004; Li and Xie
2005). We allow for the possibility that pre-malignant
stem cells are regulated somewhat less stringently than
their normal counterparts, so that a niche ﬁlled with pre-
malignant cells can contain more such cells on average
than a niche ﬁlled with normal cells.
• Aninitiated stem celleither dies out, or grows into a pre-
malignant clone, which quickly (e.g., within a year,
Campbell et al. 1996) ﬁlls the entire stem cell niche in
which it originated, i.e., ‘‘initiates’’ the whole niche. To
expand beyond the ﬁrst niche, the pre-malignant clone
needstoinvadeanadjacentniche;alternatively,theniche
containingtheclonecandivideintotwodaughterniches,
e.g., colon crypt ﬁssion (Greaves et al. 2006; Johnston
et al. 2007; Edwards and Chapman 2007). These
processes require years or decades, and may involve
acquisition of new mutations (Spencer et al. 2006).
• Pre-malignant cells in all niches are assumed to
gradually lose their carcinogenic potential with age, so
that at old age they have a progressively smaller
probability of beingtransformed to malignant cells.This
assumption is suggested by a decrease in incidence of
most cancers at very old age, e.g.,[80 years in humans
[Surveillance Epidemiology and End Results (SEER)
database, http://seer.cancer.gov] and[800 days in mice
(Pompei et al. 2001). The likely mechanism is senes-
cence of stem cells and/or deterioration of stem cell
function, or niche function, with age (Brunet and Rando
2007; Carlson and Conboy 2007; Sharpless and
DePinho 2007).
• To reduce the number of model parameters, clonal
expansion of pre-malignant stem cell niches is treated
deterministically, using a net proliferation rate. In other
words, it is estimated by a deterministic ‘‘exponential
model’’, instead of the stochastic TSCE model. Given
realistic parameter values, the deterministic and sto-
chastic versions of the two-stage model are numerically
very similar from birth until old age (Heidenreich and
Hoogenveen 2001). In our analyses, by the time
irradiation is over and cell repopulation in the exposed
organ has occurred, surviving pre-malignant clones
have grown to substantial sizes, making extinction very
unlikely. This reduces the need for stochastic treatment
of clone dynamics during the decades following
radiation exposure. At old age, the deterministic
approximation predicts an increasing hazard, whereas
the stochastic TSCE model predicts a plateau. Consid-
ering the evidence cited above about a decrease in
cancer incidence at old age, neither behavior is fully
realistic. We here instead model the downturn in
incidence at old age explicitly, according to the assump-
tion above.
Uniﬁcation of short- and long-term models
The integration of long- and short-term models will have
two features typical of multi-timescale modeling (Engquist
and Runborg 2005): (1) information is passed in both
directions between the two components; and (2) a formally
inﬁnite time interval in the short-term model represents a
short time interval, here typically several months, in the
long-term model (Fig. 1).
The deterministic long-term equations provide the mean
number of niches ﬁlled with pre-malignant stem cells and
the mean number of pre-malignant cells per niche just
before irradiation. The stochastic short-term equations then
provide the number of these niches that are eradicated by
radiation as well as the number of pre-malignant clones
that are induced by, and survive, the radiation exposure.
Each of these clones is assumed to be independent (i.e.,
located in a different part of the organ), and to be capable
of quickly ﬁlling a niche with pre-malignant cells. There-
fore, the total number of pre-malignant niches soon after
irradiation can be calculated by the stochastic short-term
model. The mean of this number is the initial condition for
the deterministic long-term equations, which are applied
from this point onwards until old age (Fig. 1). Cancer
incidence is assumed to be proportional to the total number
of pre-malignant cells in all niches, shifted by a lag time. A
mathematical description of the model is provided below.
Materials and methods
The mathematical techniques for implementing the assump-
tions for our speciﬁc example of integrating long- and short-
termmodelingarediscussednext.Aschematicrepresentation
of the concepts is provided in Fig. 2. The notation and inter-
pretationsfor modelparameters are listedinTable 1.Da taon
both background and radiation-induced cancers are used to
estimate the parameters.
Long-term model for background cancers
The long-term model was intended mainly to place the
results of the stochastic short-term calculations in an
Radiat Environ Biophys (2009) 48:263–274 265
123appropriate context, enabling estimation of the effects of
age at exposure and time since exposure on predicted
cancer risk. Simplicity and parsimony were emphasized.
The long-term model in the absence of radiation consists
just of a few rather simple deterministic equations, as
follows.
Each pre-malignant stem cell in any niche has a certain
smallprobabilityperunittime(qunits = cells
-1 9 time
-1)
of transforming into a fully malignant cell, and, after a ﬁxed
lag time (L), into clinical cancer. These are common
assumptions made in many long-term carcinogenesis mod-
els, e.g., in the TSCE model. The average number of new
fully malignant cells per unit time (A units = time
-1) is the
product of q and three other variables: the number of stem
cell niches ﬁlled with pre-malignant cells (M uni-
ts = niches), the average number of pre-malignant stem
cells per niche (q units = cells 9 niche
-1), and the
probability that the pre-malignant cells remain non-senes-
cent and capable of producing cancer (P). The number of
pre-malignant stem cells per niche (q) is assumed to be
homeostatically regulated (in a qualitatively similar manner
to the regulation of normal stem cells), so that it always
tends towards a constant number—a carrying capacity Z
(units = cells 9 niche
-1). For convenience, the number of
pre-malignant stem cells per niche can be redeﬁned as a
dimensionless normalized fraction C=q/Z. The propor-
tionalityconstantqZcanberemovedfromtheexpressionfor
A by deﬁning N = qZM (units = time
-1), where N is pro-
portional to the number of pre-malignant niches. Conse-
quently, A can be written in the following simpliﬁed form:
A ¼ NCP ð1Þ
Equation (1) is an approximation for the incidence
hazard function: it gives the mean expected number of new
A  B  C 
D  E  F 
G  H I 
Fig. 2 Schematic representation of proposed pre-malignant cell
kinetics. Each square represents a tissue niche. Cyan color normal
cells; other colors pre-malignant cells—each color indicates a
different clone. Black arrows invasion of an adjacent niche. The
order of panels denotes a hypothetical time sequence: a only niches
ﬁlled with normal cells are present at a young age. b Some niches
ﬁlled with pre-malignant cells are spontaneously initiated (red and
blue). c–e The pre-malignant clones expand over time by taking over
adjacent niches. f Radiation exposure (lightning symbols) perturbs the
system: some normal and pre-malignant cells are inactivated (niches
become smaller), and some niches are completely inactivated (shown
by gaps). Some new pre-malignant clones are initiated (green and
brown). g After exposure, all niches ﬁlled with pre-malignant cells
(red, blue, green, brown) expand in cell number (undergo promotion,
shown by an increase in the size of the squares). Possible promotion
of normal niches is neglected. Surviving normal and pre-malignant
niches replace the niches inactivated by radiation (shown by
disappearance of the gaps). h Over many years/decades after
irradiation, roughly normal tissue architecture is restored. The
promoting effect may disappear, as all niches return to the default
size. Meanwhile, replication of existing pre-malignant niches contin-
ues (shown by arrows), and some new clones appear by spontaneous
initiation (shown by the black square). i Subsequent mutations in one
of the pre-malignant clones produce the ﬁrst fully malignant cell,
which grows into a malignant tumor (gray mass)
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123malignant cells (i.e., eventual cancers) per individual per
year, whereas the hazard (H) given in (2) is the yearly
probability that a malignant cell occurs in a previously
healthy individual at age t:
H ¼ A= 1  
Z t
0
Adu
  
ð2Þ
The functions A and H are numerically very similar for
realistic parameter values; they diverge substantially only
if cancer incidence is high. We use the exact hazard H for
data ﬁtting in the companion paper, but use the simpler
expression for A in the equations below, keeping in mind
its interpretation and limitations.
The function N is described by the following differential
equation (3), where t is patient age, the constant a
(units = time
-2) is proportional to the spontaneous stem
cell initiation rate, and the constant b (units = time
-1)i s
the pre-malignant niche replication rate:
dN=dt ¼ a þ bN ð3Þ
Equation (3) can be adjusted to accommodate an assump-
tion that more than one mutation is needed to initiate a
stem cell by replacing the constant a with the composite
term at
j-1, where j is the necessary number of mutations.
However, doing so does not substantially improve the ﬁt of
the model to the data sets analyzed, and so was not used as
the default because it introduces an extra adjustable
parameter j. The results for ﬁtting multi-stage extensions
of our model (i.e., where j[1) to SEER data for female
breast and male lung cancers are shown in Fig. 3.
The function C is regulated by the following logistic
differential equation, where d (units = time
-1) is a rate
constant representing the strength of homeostatic control of
the number of pre-malignant cells per niche:
dC=dt ¼ dC 1   C ðÞ ð 4Þ
For background carcinogenesis the solution C = 1 is used.
The probability that the pre-malignant cells remain non-
senescent and capable of producing cancer (P) is described
by a Gaussian function with an adjustable parameter c
(units = time
-2), which cannot become negative even as
age approaches inﬁnity, contrary to the expression used by
Pompei et al. (2001) and Pompei and Wilson (2002):
P ¼ exp  ct2   
ð5Þ
For convenience later, when radiation-induced excess
relative risk (ERR) will be calculated, it is useful to express
patient age (t) as the sum of age at exposure (Tx) and time
since exposure (Ty). The background cancer risk function
without radiation (Abac(Tx, Ty)) follows from (1) and (3–5),
assuming that no pre-malignant cells are present at birth
(i.e., that N(0) = 0):
Abac Tx; Ty
  
¼ a=b ðÞ exp bT x þ Ty
     
  1
  
  exp  cT x þ Ty
   2 hi
ð6Þ
Here, the duration of radiation exposure is ignored, because
it is considered to be short compared with the multi-year
time scale of the long-term carcinogenesis processes.
Effects of radiation
Short-term processes
The exposure scenario analyzed here is radiotherapy for an
existing malignancy, where there are K daily dose-frac-
tions, all of equal size d in some nearby organ, with
treatment gaps during the weekends. Straightforward gen-
eralizations to variable doses per fraction, to other temporal
patterns, and/or to cases where one must consider dose-
volume histograms are omitted for brevity. A single acute
dose exposure is a simple special case, where the number
of fractions is K = 1.
The short-term part of the model considers initiation,
inactivation, and repopulation (iir) of normal and pre-
malignant stem cells during the radiation regimen and a
recovery period of about a month (Fig. 1). Niche takeover
by pre-malignant cells that survive the irradiation and
modulation of niche size by radiogenic promotion (dis-
cussed below) are here also considered short-term pro-
cesses. They are assumed to be essentially completed by a
few months following exposure, before the long-term
processes of spontaneous initiation and niche replication,
Table 1 Summary of model parameters
Parameter Units Interpretation
a time
-2 Spontaneous stem cell
initiation and transformation
b time
-1 Pre-malignant niche replication
c time
-2 Age-dependent pre-malignant
cell senescence
d time
-1 Homeostatic regulation of pre-
malignant cell number per
niche
Z cells/niche Carrying capacity for pre-
malignant cells per niche
X time/dose Radiation-induced initiation
Y dose
-1 Radiation-induced promotion
a, b dose
-1, dose
-2 Stem cell inactivation by
radiation
k time
-1 Maximum net stem cell
proliferation (repopulation)
rate
L time Lag period between the ﬁrst
malignant cell and cancer
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123which operate on the time scale of multiple years, start to
have an appreciable effect (Fig. 1).
Normal stem cells are treated deterministically because
their number per organ is assumed to be large. In contrast,
the number of pre-malignant stem cells per clone is much
smaller, and extinction of some pre-malignant clones is a
real possibility. Consequently, a stochastic approach
described below is used to estimate the average number of
live pre-malignant niches when post-irradiation long-term
processes begin.
For simplicity, both normal and pre-malignant stem
cells are assumed to be equally radiosensitive. The cell
surviving fraction (S) is described by the standard linear-
quadratic (LQ) function with parameters a and b for dose-
fractions of size d:
S ¼ exp  ad   bd2   
ð7Þ
The normal stem cell number (n) in the entire organ just
before the kth dose-fraction is denoted by n
-(k), and the
number just after the kth dose-fraction by n
?(k). The
reduction in n due to initiation of a few normal stem cells is
neglected. Inactivation is calculated as follows:
nþ k ðÞ¼Sn  k ðÞ ð 8Þ
Repopulation of normal stem cells during radiotherapy
is assumed to be regulated by homeostatic mechanisms—if
some stem cells are killed by radiation, surviving stem cells
are induced to proliferate (Do ¨rr and Kummermehr 1990;
Pabst et al. 2004) with the goal of restoring the total
number of normal stem cells in the organ (n) to the number
present before irradiation (m). It should be noted that m is
conceptually and numerically distinct from the carrying
capacity Z introduced above for pre-malignant stem cells
per pre-malignant niche. The homeostatic regulation of cell
proliferation during the time gaps between dose-fractions
and after the last fraction is described by the Logistic
differential equation, where k (with units = time
-1) is the
maximum net proliferation rate:
dn=dt ¼ kn 1   n=m ½  ð 9Þ
Equations (7–9) allow the calculation of the normal
stem cell number n(t) in the entire organ at all relevant
times t throughout the radiation exposure and recovery
periods. Explicit results for n(t) are provided in the
Appendix.
We assume that the long-term growth advantage of pre-
malignant cells manifests itself only on the scale of years
and decades, and is negligible on the much shorter time
scale of a few weeks of radiotherapy. Consequently, the
maximum net proliferation rates for normal and pre-
malignant stem cells are assumed to be equal, described by
the parameter k.
As discussed above, radiation initiates some normal
stem cells, making them pre-malignant. The number of
cells initiated in the kth dose-fraction is assumed to be
Poisson distributed, with average aXI(k), where X is an
adjustable parameter (units = time 9 dose
-1) and the
function I(k) (units = dose) is given by:
Ik ðÞ¼ dSn  k ðÞ =m ¼ dnþ k ðÞ =m ð10Þ
Our assumptions allow the birth, death, and initiation
rates for normal stem cells calculated deterministically by
(7–10) to be used as parameters for a stochastic formalism
for pre-malignant cell clones. Each such clone is initiated
as a single cell in some random niche by the kth dose-
fraction, and can ﬂuctuate in cell number during
subsequent radiotherapy due to the opposing effects of
inactivation and repopulation. We count the number of
clones that contain at least one viable cell when
radiotherapy ends, because only these surviving clones
are capable of eventually taking over their niches. Their
number is determined by the probability F(k) that a live
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Fig. 3 Fits of the long-term part of our model to spontaneous
incidence data for female breast and male lung cancers from SEER
(the data for young ages were excluded because cancer incidence in
these age groups is likely to be dominated by genetic predisposition).
Error bars represent 95% conﬁdence intervals. The different curves
represent our default two-stage formalism and its multi-stage
extensions described in the main text. These extended versions of
the formalism do not alter the ﬁt substantially
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123stem cell initiated by the kth dose-fraction produces a
clonal lineage, which survives all subsequent dose-
fractions. Using analytic results on stochastic birth–death
processes with variable rates (Tan 2002; Hanin 2004) the
Appendix derives an equation, (22), for F(k), which is
repeated here:
FðkÞ¼
1
DðkÞ
;
where DðkÞ¼nþðkÞ 1 þ
X K
j¼k
n ðj þ 1Þ nþðjÞ
n ðj þ 1ÞnþðjÞ
"#
:
Here, F(0) is the probability that a pre-malignant cell that
was present before irradiation began produces a lineage
which survives all dose-fractions.
Using the facts that a random thinning of a Poisson
distribution is Poisson and the sum of independent Poisson
distributions is Poisson, one can show that the total number
of surviving pre-malignant clones at the end of the short-
term period is Poisson distributed. The above arguments
give the mean value as Ninit = aXISf(D), where D is the
total radiation dose (i.e., the sum of all doses per fraction,
dK) and ISf(D) (units = dose) represents a net outcome of
initiation, inactivation, and cell repopulation during expo-
sure, ISf D ðÞ ¼
PK
k¼1 IðkÞFðkÞ: The probability that a pre-
malignant niche that was present before exposure is not
inactivated by radiation (i.e., that at least one pre-malignant
stem cell in the niche survives) is given by:
Sf Z;D ðÞ ¼ 1   1   F 0 ðÞ ½ 
Z ð11Þ
Unifying short- and long-term processes
The above short-term processes are regarded as effectively
instantaneous relative to the long-term ones. The stochastic
results for the short-term exposure period, in the form of
the functions ISf(D) and Sf(Z, D), are inserted into the
deterministic equations for long-term carcinogenesis pro-
cesses. On the long-term time scale, niches already pre-
malignant at the end of irradiation and recovery then
increase in number by replication; we will refer to all the
resulting niches as ‘‘old’’ niches. Other, ‘‘new’’ niches are
formed by spontaneous initiation after the end of the
exposure period. The contributions of niches in these two
categories to the cancer risk are called NradE(Tx, Ty) and
NradN(Tx, Ty), respectively. At a given time (Ty) after
irradiation they are given by the following solutions for (3):
NradET x;Ty
  
¼ a=b ðÞ exp bTx ½    1 ðÞ Sf Z;D ðÞ ½
þaXISf D ðÞ   exp bTy
  
NradNT x;Ty
  
¼ a=b ðÞ exp bTy
  
  1
  
ð12Þ
Radiation is commonly assumed to promote hyper-
proliferation of pre-malignant cells (Heidenreich et al.
2007). Here, we interpret this effect as an increase in the
number of pre-malignant stem cells per surviving niche
above the niche carrying capacity Z, i.e., C becomes [1.
For simplicity, the initial excess of C is assumed to be
linearly dependent on radiation dose with the coefﬁcient Y
(units = dose
-1). Promotion may be eventually reversed,
because the number of pre-malignant cells per pre-
malignant niche may gradually return to pre-irradiation
carrying capacity Z. This process may occur concurrently
with extinction of some radiation-induced niches (Zhang
et al. 2001; Ullrich 1986). Since only the product of the
number of niches and the number of cells per niche is
relevant for cancer risk (1), extinction of some niches and/
or shrinkage of niche size do not need to be modeled
separately. The net effect—i.e., a gradual reversal of
promotion—can be modeled using only one adjustable
parameter (d), as done here. According to these
assumptions, at any given time (Ty) after exposure to
radiation the average normalized number of pre-malignant
cells per surviving niche (Crad(Tx, Ty)) can be calculated by
solving (4):
Crad Tx;Ty
  
¼ 1 þ YD ðÞ = 1 þ YD 1   exp  dTy
        
ð13Þ
Calculation of absolute and relative cancer risks
The approximation for the absolute cancer risk after radi-
ation (Arad(Tx, Ty)) can now be calculated at any age at
exposure and time since exposure by using the equations
above:
AradðTx; TyÞ¼ NradEðTx;TyÞCradðTx;TyÞ
 
þNradNðTx;TyÞ
 
PðTx;TyÞ
¼
a
b
ðexp½bTx  1ÞSfðZ;DÞþbXISfðDÞexp½bTy ð1þYDÞ
1þYDð1 exp½ dTy Þ
 
þexp½bTy  1
 
exp  cðTx þTyÞ
2
hi
ð14Þ
The excess relative cancer risk (ERR) follows from (6)
and (14): ERR = [Arad(Tx, Ty)/Abac(Tx, Ty)] - 1. By
substitution and simpliﬁcation, a more explicit expression
for the ERR can be obtained:
ERR ¼ Q1Q2 þ Q3 ðÞ =Q4 ½    1; where
Q1 ¼ 1 þ YD ðÞ = 1 þ YD 1   exp  dTy
        
;
Q2 ¼ exp bTx ½    1 ðÞ Sf Z;D ðÞ þ bXISf D ðÞ ½  exp bTy
  
;
Q3 ¼exp bTy
  
  1;
Q4 ¼exp bT x þ Ty
     
  1 ð15Þ
Note that the senescence parameter (c) cancels out of
this ERR expression; due to the way we have deﬁned our
radiation initiation parameter (X), the spontaneous
initiation parameter (a) also cancels out. The term Q1 can
be interpreted as the normalized size of old pre-malignant
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123stem cell niches. Q2 is proportional to the number of such
niches. Q3 is proportional to the number of new pre-
malignant niches, and Q4 is proportional to the total
number of pre-malignant niches under background
conditions.
Results
To display the properties of the model, we produced
Figs. 4–7 using generic parameter values guided by the
best-ﬁt values for speciﬁc cancer sites found in the
accompanying paper (Shuryak et al. 2009).
Figure 4 shows an example of a model-generated age-
dependent background incidence curve for an adult-onset
solid cancer, using the four relevant parameters a, b, c, and
L. The shape of this curve agrees well with the data for
many cancers (e.g., SEER database, http://seer.cancer.gov),
including the downturn in incidence at old age, which is
not described as well by standard models.
Figure 5 shows a typical radiation dose–response, which
is determined by the balance of cell initiation, inactivation
(killing), and repopulation. Fractionation of the dose
increases cancer ERR because repopulation of both normal
and pre-malignant cells during the inter-fraction intervals
compensates for much of the cell killing.
Figures 6 and 7 show the effects of age at exposure and
time since exposure. The components of cancer ERR
produced by radiation-induced initiation and radiation-
induced promotion exhibit very different dependences on
age at exposure. Radiation is assumed to initiate the same
number of cells per unit dose independent of age, whereas
the background number of pre-malignant cells, which is
essentially the denominator of ERR, grows with age.
Consequently, the initiation-driven component of ERR
decreases with age at exposure. This process dominates the
ERR for ages\20 years in Fig. 6. In contrast, promotion is
assumed to be a multiplicative ampliﬁcation of the back-
ground number of pre-malignant cells per niche. Conse-
quently, the promotion-driven component of ERR is
approximately constant over most ages at exposure. This
process dominates the ERR for older ages in Fig. 6.
Promotion-driven ERR can also be modulated by time
after exposure. This occurs due to the assumption that the
number of pre-malignant cells per niche is homeostatically
regulated (by parameter d), so that radiation-induced
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Fig. 4 The typical shape for age dependence of background incidence
foraspeciﬁctypeofadult-onsetsolidcancerisreasonablyreproducedby
our model. The curve was generated using the following parameter
values: a = 1.0 9 10
-8 y
-2, b = 0.25 y
-1, c = 1.75 9 10
-3 y
-2,
L = 10 y
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Fig. 5 The effect of dose-fractionation on predicted excess relative
cancer risk (ERR): as the same total radiation dose is split into
fractions (one fraction per day, with gaps on weekends), thereby
protracting it over a longer time, cancer risk predicted by the model
increases. This occurs because cell repopulation during prolonged
exposure partially compensates for cell killing by radiation. The doses
refer to a given organ, such as the lungs or female breast, and not to
whole body exposures. The following parameter values were used:
b = 0.25 y
-1, X = 10.0 y 9 Gy
-1, Y = 0.5 Gy
-1, d = 0.01 y
-1,
Z = 10.0 cells/niche, a = 0.3 Gy
-1, b = 0.0 Gy
-2, k = 0.35 day
-1,
Tx = 30 y, Ty = 0.0 y, and L = 10 y
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Fig. 6 Combined effects of age at exposure and time after exposure
on radiation-induced excess relative cancer risk (ERR). The ERR is
calculated at age 70, which is intended to approximate lifetime risk.
As discussed in the text, only age at exposure matters if parameter
d = 0, but if d[0, time after exposure affects the ERR as well. The
parameter values were the same as in Fig. 5, except for Tx and Ty, and
a reference radiation dose of 1 Gy
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123hyper-proliferation of cells within their niches can be
reversed, as pre-irradiation cell birth/death rates, and hence
niche sizes, are restored. If d[0, ERR due to promotion
will decrease over time following exposure. This effect is
seen in Figs. 6, 7: If the risk is measured at some constant
age (e.g., 70 years), which is a sum of age at exposure and
time since exposure, a decrease in ERR with time since
exposure due to a d[0 will appear as an increase in the
ERR with age at exposure (Fig. 6). A decrease in promo-
tion-driven ERR with time since exposure also can have a
conceptually important effect on the dose–response—at
longer times after exposure, not only the magnitude, but
also the shape, of the dose–response can change (Fig. 7).
Discussion
The formalism presented here is the ﬁrst comprehensive
attempt to unify short- and long-term modeling approaches.
The short-term part of the model belongs to the previously
discussed iir category. It tracks the numbers of pre-
malignant cells throughout irradiation stochastically. The
long-term part of the model builds on the concepts devel-
oped in previous two-stage formalisms by adding an
analysis of some aspects of tissue architecture (i.e., stem
cell niches/compartments) and aging of pre-malignant stem
cells. The particular short and long-term models that we
have chosen to use are not crucial—the real issue is the
integration. Certainly other long-term models could per-
fectly well be integrated into this short-/long-term frame-
work—and we hope they will be.
The uniﬁed formalism has a number of advantages. The
short-term part can generate reasonable predictions even at
high doses, such as those in cancer radiotherapy. The long-
term part analyzes the entire lifetime of the individual,
putting the short-term predictions in an appropriate context
by estimating the effects of age at exposure and time since
exposure. The combined approach therefore allows the
dose–response for the number of pre-malignant cells to be
examined at any time point, from the start of irradiation
until development of cancer years to decades later, which is
not possible using either short- or long-term models alone.
Our model can be used for estimating risks of second
malignancies induced by radiotherapy. This issue is
growing in importance (Brenner et al. 2000; Ron 2006)a s
patients are treated earlier in life and the number of cancer
survivors increases (Editorial 2004); the lifetime risk of
radiation-induced second cancers is not negligible (Brenner
et al. 2007). Direct measurement of second cancer inci-
dence requires decades of follow-up because the latency
period for radiogenic solid tumors is long (Tokunaga et al.
1979; Brenner et al. 2000; Ivanov et al. 2004, 2009).
Meanwhile, radiotherapy protocols are rapidly changing.
Our model, calibrated using data from older protocols, can
produce risk predictions for any modern or prospective
radiotherapeutic protocol. This application of the model is
discussed in the accompanying paper (Shuryak et al. 2009).
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Appendix
This appendix gives some details on the equations for the
short-term calculation and on their derivation. We ﬁrst
analyze repopulation effects for normal stem cells
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Fig. 7 Modulation of promotion-driven excess relative cancer risk
(ERR) over time after exposure: a low doses (either acute or
fractionated produce similar results, since cell inactivation is negli-
gible), b high fractionated doses (fractions are given once daily, with
gaps on weekends). It is seen that, contrary to a proportional hazards
assumption, not only the amplitude but also the shape of the dose–
response curve is altered by long-term processes. The parameters
were the same as in previous ﬁgures
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123deterministically (16–18); then we analyze survival prob-
abilities for pre-malignant clones stochastically. The
equations derived are extensions of results given previously
(Sachs et al. 2007).
Normal stem cell numbers
Denote the time of the kth dose-fraction by T(k). We will
derive recursive equations valid for k=1 ,…, K, where the
number of fractions is K as in the main text. We formally
deﬁne T(K ? 1) :? ; this inﬁnite value represents the end
of the recovery period (Fig. 1). It reﬂects a standard pro-
cedure in multi-timescale analyses (Engquist and Runborg
2005), an inﬁnite time interval in a short-timescale model
represents a short time interval in the next larger timescale
model (here several months in our long-timescale model).
We correspondingly set n
-(K ? 1) = m, the set point value
attained at the end of the recovery period.
Solving (9) of the main text gives n(t) for any time t
after the kth dose-fraction and before the (k ? 1)st:
nðtÞ¼
nþðkÞm
nþðkÞþ m   n ðkÞ ½  exp  k½t   TðkÞ  ½ 
:
for Tk ðÞ \t\Tk þ 1 ðÞ ð 16Þ
In particular, for n
-(k ? 1), 16 gives:
n ðk þ 1Þ
¼
nþðkÞm
nþðkÞþ m   n ðkÞ ½  exp  k½Tðk þ 1Þ TðkÞ  ½ 
: ð17Þ
Normal stem cell number n(t) can be calculated
recursively for all times by combining the proliferation
equations,(16)and(17),withthesurvivalequationdiscussed
in the main text:
nþðkÞ¼SðkÞn ðkÞ; where SðkÞ¼exp½ ad   bd2 :
ð18Þ
Pre-malignant stem cell clones
To analyze pre-malignant clones stochastically, consider a
clone that starts with a single live stem cell initiated by the
kth dose-fraction, and is followed in time. The time evo-
lution of the clone is modeled as a time inhomogeneous
birth–death process with birth rate b(t) and death rate r(t)
(Tan 2002). The appropriate death rate, taking the spon-
taneous death rate as zero to minimize the number of
adjustable parameters, is the death rate due to the dose-
fractions, namely
rðtÞ¼
X K
k¼1
½ad þ bd2 d t   TðkÞ ½  ; ð19Þ
where d [t] is the Dirac delta function.
Equation (19) corresponds to the statements that on
average the surviving cell fraction for the kth dose-fraction
is given by (18) and that pre-malignant stem cells have the
same radiosensitivity to inactivation as do normal stem
cells. By our assumption that, during the comparatively
short radiotherapy and recovery periods, normal and pre-
malignant cells have effectively the same proliferation rate,
the appropriate birth rate is
b t ðÞ¼k 1   n t ðÞ =m ½  ðÞ ð 20Þ
In (20) n(t) is a known function of time, determined as
discussed above.
It is well known (Tan 2002, pp. 169–171) that by inte-
grating an appropriate partial differential equation for the
probability generating function one can deduce the following
expression for the probability F(k) that the pre-malignant
clone survives all subsequent dose-fractions:
FðkÞ¼ 1=ðn þ fÞ; where
wðtÞ¼exp
Z t
TþðkÞ
rðuÞ bðuÞ ½  du
"#
;
n ¼ wðTþðK)), and f ¼
Z TðKÞ
TðkÞ
bðtÞwðtÞdt:
ð21Þ
Here, T
?(k) denotes the time just after the kth
fraction. Because of the way a Dirac d function behaves,
using T
? rather than T is important in the expressions for w
and n.
Performing the integrals in (21) with the help of (16–20)
gives, after a quite long, but routine, calculation, the fol-
lowing convenient equation for the clone survival proba-
bility F(k):
FðkÞ¼
1
DðkÞ
;
where DðkÞ¼nþðkÞ 1 þ
X K
j¼k
n ðj þ 1Þ nþðjÞ
n ðj þ 1ÞnþðjÞ
"#
:
ð22Þ
Equation (22) is valid for k = 0, 1,…, K,w i t hk = 0
referring to pre-malignant cells present before radiation
starts and F(K) = 1. It is the primary mathematical result
needed for the data analysis discussed in the main text.
We have some extensions, not needed in the present
paper. Generalizing to situations where the spontaneous
death rate is non-zero and/or one needs the probability that
a clone has a given number of cells at the ﬁnal time, can
readily be done by using results given by Tan (2002). In
addition, it can be shown that (22) holds even if the
recovery equation for normal cells is different from the
logistic equation used in this paper, e.g., is Gompertzian.
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